Journal article
Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial
Abstract
BACKGROUND: Algae-derived nutraceuticals, such as spirulina, have been reported to have biological activities that may minimize clinical consequences to COVID-19 infections.
OBJECTIVES: This study aimed to determine whether spirulina is an effective treatment for high-risk patients with early COVID-19 in an outpatient setting.
Authors
Reis G; Augusto Dos Santos Moreira Silva E; Carla Medeiros Silva D; Thabane L; Santiago Ferreira T; Vitor Quirino Dos Santos C; Paula Figueiredo Guimaraes Almeida A; Cançado Monteiro Savassi L; Dias de Figueiredo Neto A; Lanna França Reis L
Journal
American Journal of Clinical Nutrition, Vol. 120, No. 3, pp. 602–609
Publisher
Elsevier
Publication Date
September 2024
DOI
10.1016/j.ajcnut.2024.06.016
ISSN
0002-9165